Viekira Pak ombitasvir/paritaprevir/ritonavir plus dasabuvir: Interim Phase IIIb data

Interim data from the open-label, U.S. Phase IIIb TOPAZ-II trial in 615 treatment-naive or treatment-experienced patients with chronic HCV genotype 1 infection with or without compensated cirrhosis sh...